- Home
- HAO vs TOVX Comparison
HAO vs TOVX Comparison
Compare HAO & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAO
- TOVX
- Stock Information
- Founded
- HAO 2018
- TOVX 2001
- Country
- HAO China
- TOVX United States
- Employees
- HAO N/A
- TOVX N/A
- Industry
- HAO
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- HAO
- TOVX Health Care
- Exchange
- HAO NYSE
- TOVX Nasdaq
- Market Cap
- HAO 3.3M
- TOVX 3.8M
- IPO Year
- HAO 2024
- TOVX 2006
- Fundamental
- Price
- HAO $1.39
- TOVX $0.47
- Analyst Decision
- HAO
- TOVX Hold
- Analyst Count
- HAO 0
- TOVX 1
- Target Price
- HAO N/A
- TOVX N/A
- AVG Volume (30 Days)
- HAO 139.3K
- TOVX 1.8M
- Earning Date
- HAO 06-13-2025
- TOVX 05-14-2025
- Dividend Yield
- HAO N/A
- TOVX N/A
- EPS Growth
- HAO N/A
- TOVX N/A
- EPS
- HAO 0.19
- TOVX N/A
- Revenue
- HAO $48,970,924.00
- TOVX N/A
- Revenue This Year
- HAO N/A
- TOVX N/A
- Revenue Next Year
- HAO N/A
- TOVX N/A
- P/E Ratio
- HAO $7.17
- TOVX N/A
- Revenue Growth
- HAO 15.04
- TOVX N/A
- 52 Week Low
- HAO $0.84
- TOVX $0.40
- 52 Week High
- HAO $187.00
- TOVX $7.37
- Technical
- Relative Strength Index (RSI)
- HAO 49.11
- TOVX 29.91
- Support Level
- HAO $1.37
- TOVX $0.43
- Resistance Level
- HAO $1.55
- TOVX $0.54
- Average True Range (ATR)
- HAO 0.29
- TOVX 0.05
- MACD
- HAO -0.01
- TOVX 0.03
- Stochastic Oscillator
- HAO 32.10
- TOVX 41.18
About HAO HAOXI HEALTH TECHNOLOGY LTD
Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. Haoxi has been rooted in the field of local online effect marketing for many years, serving customers in various industries at home and abroad, and its main business is the medical industry. It generates its revenue by providing one-stop online marketing solutions, in particular online short video marketing solutions, to advertisers through its media partners. The company provides customized marketing solutions by planning, producing, placing, and optimizing online ads, especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.